PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham HIP for CHD Jane Matthews Practice Nurse Dr. Dai Evans PRIMIS Regional Clinical Adviser.

Slides:



Advertisements
Similar presentations
Ten years of the CHD NSF Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health.
Advertisements

Unstable angina and NSTEMI
CHD REGISTERS ADELE GRAHAM PROJECT MANAGER WEST YORKSHIRE CHD COLLABORATIVE.
Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.
Summary Prepared by Melvyn Rubenfire, MD
ASCOT Lancet, April 2003 n=10,305 Evidence for: primary prevention of CHD and stroke in high risk, middle aged, hypertensive, male patients with TC
May 2005 CHD Health Equity Audit PRIMIS Fifth Annual Conference 11 – 12 May 2005 Piecing Together the Future Vicky Smith Jane Robinson.
New Atrial Fibrillation/Flutter Pathway and GRASP Tool
Heart Failure Diagnosis and Management in Primary Care Dr David Ebbs GP, Didcot Health Centre GPwSI Heart Failure, OxonPCT.
Clinical Performance Development in NHS Direct Dr Andrew Lee NAGPC Annual Conference March 2004.
National Service Frameworks Dr Stephen Newell February 2002.
National Service Framework for diabetes Ruth BarnesMina Fernando Director of Public HealthDiabetes Manager.
Ischaemic Heart Disease- Implications of Gender Dr Kaye Birks School of Rural Health Monash University Australia Gender Competency Training for Medical.
Coronary heart disease (CHD) event rates in secondary prevention and acute coronary syndrome trials A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125.
Fylde Coast Integrated Diabetes Care
Wellness S Y M P O S I U M Darwin R. Labarthe, MD, MPH, PhD Director, Division for Heart Disease and Stroke Prevention.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Commissioning to reduce health inequalities: Supporting analysis
Dr Verity Blackwell West Hertfordshire Dermatology Team.
1 Obesity Treatment in Special Populations Smokers –All smokers, regardless of weight, should quit smoking. –Implement weight gain prevention, treatment.
Managing depression in people with long term conditions Chris Dickens Professor of Psychological Medicine Peninsula College of Medicine and Dentistry.
Population Impact Measures (PIM)
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Inequalities in coronary heart disease treatment Professor Azeem Majeed University College London.
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
Risk estimation and the prevention of cardiovascular disease SIGN 97.
Using research to inform and change primary care Professor James Dunbar Greater Green Triangle UDRH
Tackling Coronary Heart Disease. Inequality in CHD services health outcomes how much? What is to be done? Population public health interventions.
Management of Stable Angina SIGN 96
National Service Framework NSF sets out 12 standards covering the following areasNSF sets out 12 standards covering the following areas –Reducing heart.
Planning David Bonson April March-May We are here Final draft of plan.
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
Incremental Decrease in Clinical Endpoints Through Aggressive Lipid Lowering (IDEAL) Trial IDEAL Trial Presented at The American Heart Association Scientific.
Studying mortality trends: The IMPACT CHD Policy Model
Cardiac MCN April 2007 Tackling Health Inequalities: Keep Well Programme.
Collaborative Atorvastatin Diabetes Study CARDS Dr Sachin Kadoo.
Chronic Disease Management Why is this an important issue? High numbers of patients affected Effective interventions may be available Concern that there.
Cardiovascular Outcome Strategy Implications for Primary Care Westcliffe Medical Practice Shipley Westcliffe Cardiology Service Dr Matthew Fay Westcliffe.
Coronary Revascularisation: the DoH View Dr Roger Boyle National Director for Heart Disease.
Management of coronary heart disease in primary care Professor Azeem Majeed Primary Care Research Unit University College London.
ELIGIBILITY: MRC/BHF Heart Protection Study Increased risk of CHD death due to prior disease: Myocardial infarction or other coronary heart disease; Occlusive.
CVD MEETING 7/9/01: main topics CV CLINIC WITH SCREEN SHOTS AND AUDIT MANAGEMENT PROTOCOL WITH DRUGS AND RISK CALCULATION CHARTS ASPIRIN AUDIT.
The Management of People at High Risk of CVD Dr Richard Healicon Mel Varvel NHS Improvement.
PUTTING PREVENTION FIRST Vascular Checks Dr Bill Kirkup Associate NHS Medical Director.
PUTTING PREVENTION FIRST Vascular Checks/ NHS Health Checks.
Clinical pathway for people with atrial fibrillation or at risk of atrial fibrillation Dr Ruth Chambers OBE LTC Priority Lead, West Midlands Academic Health.
NHS Health Check programme An opportunity to engage 15 million people to live well for longer Louise Cleaver National Programme Support Manager.
Health Inequalities. South Tyneside Life Expectancy Gap Life Expectancy – Males Local Value England England England average worst best
Hypertension November 2016
ELIGIBILITY: MRC/BHF Heart Protection Study
Towards a Smokefree Generation: A Tobacco Control Plan for England South West Clinical Senate 21 September 2017
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Prevention Cardiovascular disease
Fiona Caplan-Dean Pharmacy Services Development Manager UK
Improving outcomes for CVD
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
CVD Secondary Prevention plans within Thames Valley
Section 9: Continuum of care: Summary and timeline
Exercise-Based Cardiac Rehabilitation and Improvements in Cardiorespiratory Fitness: Implications Regarding Patient Benefit  Barry A. Franklin, PhD  Mayo.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Hypertension November 2016
Goals & Guidelines A summary of international guidelines for CHD
CVD Secondary Prevention plans within Thames Valley
Heart Disease Dr Stasinos Theodorou
Special Considerations for Different Population Groups
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham HIP for CHD Jane Matthews Practice Nurse Dr. Dai Evans PRIMIS Regional Clinical Adviser

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham Coronary Heart Disease The size of the problem Kills more than 110,000 people a year in England Of these, 41,000 are under the age of 75 years 1.4 million people in the UK have angina 300,000 people have an MI each year 46% CHD related deaths occur in people with established disease 3–5% of GP population have CHD

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham Coronary Heart Disease Exemplifies inequalities in health Ethnic variations Research has led to better evidence to guide the treatment of CHD Many patients do not receive treatment of proven effectiveness Huge variations in quality and access to services

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham NSF for CHD Launched March 2000 Established national standards for prevention and treatment of CHD Defined targets and goals to be achieved within agreed timescales Progress can be measured against performance indicators

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham NSF for CHD Standards 1 and 2 reducing Heart Disease in the population Develop, implement and monitor policies that reduce the prevalence of CHD risk factors in the population, and reduce inequalities in risk of developing CHD Contribute to a reduction in the prevalence of smoking in the local population

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham NSF for CHD Standard 3 preventing CHD in high risk patients Secondary prevention General Practitioners and Primary Health Care Teams should identify all people with established cardiovascular disease, and offer them comprehensive advice and appropriate treatment to reduce their risks

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham NSF for CHD Standard 4 preventing CHD in high risk patients Primary prevention General Practitioners and Primary Health Care Teams should identify all people at significant risk of cardiovascular disease who have not developed symptoms, and offer them appropriate advice and treatment to reduce their risk

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham NSF for CHD Standards Standards 5,6 and 7 Heart attacks and other acute coronary syndromes Standards 8 and 9 Stable angina Standard 10 Revascularisation Standard 11 Heart failure Standard 12 Cardiac rehabilitation

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham NSF for CHD Immediate priority – changing behaviour Smoking Stop smoking advice Nicotine replacement therapy Include advice on reduction of CHD risk

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham NSF for CHD Use of effective treatment Anti-platelet therapy / anticoagulation IHD / CVD / AF Lowering cholesterol Dietary advice Statins Control of B/P <140/85 Beta-blockers post MI ACE inhibitors post MI / LV dysfunction

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham NSF for CHD Effective use of clinical systems To identify people with CHD disease register To identify people at high risk of developing CHD To assist in the regular review of patients with CHD record lifestyle data / advice record events / changes in management document prescribing practice manage concurrent disease

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham NSF for CHD Primary Care milestones and goals April 2001 A systematically developed and maintained practice-based CHD register is in place, and actively used to provide structured care to people with CHD

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham NSF for CHD Primary Care milestones and goals April 2002 A protocol describing the systematic assessment, treatment, and follow up of people with CHD has been agreed locally, and is used to provide structured care

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham April 2003 Clinical audit data no more than 12 months old which describes use of relevant effective interventions in primary care, angina and heart failure which records the offer of advice about the specific interventions to those in whom they are indicated NSF for CHD Primary Care milestones and goals

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham NSF for CHD Computer templates Data entry screens which allow the user to record specific information to be used in the management of health and disease processes Can be set to be activated by the use of specific Read codes

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham NSF for CHD Templates Advantages consistent efficient prompts the need for management change Disadvantages time consuming inflexible complicated

PRIMIS Third National Conference Tuesday 1 April 2003 Birmingham NSF for CHD Making it happen Team approach regular meetings annual audit annual plan decision making CHD specialist nurse co-ordinates care IT is a tool